1 Grant
2016
A Novel STAT3 Inhibitor Targeting its DNA-Binding Site for Drug Development
LIU, JINGYUAN
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R41CA195777-01A1), $279,838USD, 09/01/2016 -- 08/31/2017